Infliximab: A phase II trial of the tumour necrosis factor (TNFα) monoclonal antibody in patients with advanced renal cell cancer (RCC)
2004 ◽
Vol 22
(14_suppl)
◽
pp. 4514-4514
2004 ◽
Vol 22
(14_suppl)
◽
pp. 4514-4514
◽